Home/Filings/4/0001104659-22-071075
4//SEC Filing

Deflin Gayle 4

Accession 0001104659-22-071075

CIK 0001297184other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 5:25 PM ET

Size

6.9 KB

Accession

0001104659-22-071075

Insider Transaction Report

Form 4
Period: 2022-06-10
Deflin Gayle
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-06-10+10,98410,984 total
    Exercise: $30.02Exp: 2030-06-10Common Stock (10,984 underlying)
  • Award

    Common Stock

    2022-06-10+4,16310,182 total
Footnotes (2)
  • [F1]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 10, 2023.
  • [F2]All of the shares subject to the option vest on June 10, 2023.

Issuer

Amphastar Pharmaceuticals, Inc.

CIK 0001297184

Entity typeother

Related Parties

1
  • filerCIK 0001866024

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:25 PM ET
Size
6.9 KB